Table 1.
Demographic and clinical parameters of study participants.
| Variables and parameters | Control group | PCOS group | P value |
|---|---|---|---|
| Demographic variables and Clinical features | |||
| N | 25 | 23 | – |
| Age (year) | 27.47 ± 5.8 | 27 ± 6 | – |
| Body Mass Index (kg/ m2) | 24.76 ± 5.6 | 24.98 ± 5.15 | > 0.05 |
| Waist-to-hip ratio | 0.77 ± 0.05 | 0.78 ± 0.07 | > 0.05 |
| LH (mIU/ml) | 5.22 ± 3.1 | 6.30 ± 4.3 | > 0.05 |
| FSH (mIU/ml) | 11.29 ± 7.8 | 7.99 ± 2.5 | 0.05 |
| LH/FSH | 0.55 ± 0.29 | 0.84 ± 0.73 | 0.04 |
| PRL (ng/ml) | 19.14 ± 9.74 | 26.84 ± 32.71 | > 0.05 |
| T (ng/dl) | 14.67 ± 4.9 | 34.56 ± 36.08 | 0.01 |
| E2 (pg/ml) | 84.09 ± 18.04 | 69.38 ± 23.24 | 0.01 |
| TSH (uIU/ml) | 2.17 ± 1.4 | 1.8 ± 0.99 | > 0.05 |
| DHEAS (ug/dl) | 143.56 ± 50.04 | 166. 17 ± 105.05 | > 0.05 |
| Hirsutism (Ferriman-Gallwey) | 5.91 ± 2.8 | 9.65 ± 5.9 | 0.001 |
| Gut bacterial enzyme activity | |||
| Total Protein (mg/ml) | 1.35 ± 0.28 | 1.43 ± 0.31 | > 0.05 |
| β-glucuronidase (mM/mg/hr) | 0.04 ± 0.01 | 0.05 ± 0.01 | 0.01 |
| β-glucosidase (mM/mg/hr) | 0.09 ± 0.05 | 0.13 ± 0.08 | > 0.05 |